在患有转酶缺乏症的儿科患者中成功进行肝移植
Ahmet Atasever1,2, Sinan Efe Yazici1,2, Ebru Turan3
1Department of General Surgery, Faculty of Medicine, Demiroglu Bilim University, Istanbul, Türkiye.
Pediatric transplantation
|February 24, 2025
概括
肝移植为患有罕见代谢障碍的转阿尔多酶缺乏症 (TALDO) 的儿童提供了一种拯救生命的选择. 这项案例研究显示了成功的结果,解决了关键症状,改善了移植后的肝功能.
科学领域:
- 生物化学 生物化学
- 遗传学 遗传学 是一个
- 儿科医学 儿科医学
背景情况:
- 转酶缺乏症 (TALDO) 是一种罕见的自体逆向性疾病,影响酸通路.
- 它带来严重的并发症,包括末期肝病,管功能障碍和凝血病.
- 目前对高级TALDO的治疗选择有限,肝移植是一种新兴但鲜为人知的治疗方法.
研究的目的:
- 报告一个成功的活体捐赠者肝移植在一个小儿病患者与转阿尔多酶缺乏.
- 为了将临床结果与之前报告的TALDO肝移植病例进行比较.
- 突出肝移植作为TALDO治疗干预的潜力.
主要方法:
- 一份病例报告详细介绍了一名接受活体供体肝移植的TALDO儿科患者.
- 综合审查和分析临床,手术前,手术和术后数据.
- 将患者的数据与有关TALDO肝移植的现有文献进行比较.
主要成果:
- 一名患有TALDO和末期肝病,出血问题和疑似HCC的3岁女孩接受了肝移植.
- 凝血病和出血的术后解决,在一年后肝功能稳定.
- 组织病理学证实了没有HCC的肝硬化;胆道狭窄症得到了成功的管理.
结论:
- 肝移植是TALDO患者终期肝病的可行,拯救生命的治疗方法.
- 短期结果令人鼓舞,但长期的预后和增长需要进一步调查.
- 持续报告病例对于完善TALDO的管理策略至关重要.
相关概念视频
01:28Kidney Transplant I: Introduction
827
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
827
01:26Kidney Transplant II: Surgical Procedure
926
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
926